Influenza Treatment Global Market Report 2025

Description

Influenza treatment involves medical measures intended to manage and relieve symptoms, shorten the duration of illness, and prevent complications linked to influenza virus infections. It includes antiviral drugs and supportive care aimed at alleviating flu symptoms, shortening the illness duration, and averting severe complications.

The primary products employed for treating influenza include peramivir, zanamivir, oseltamivir phosphate, baloxavir marboxil, and others. Peramivir is an antiviral drug utilized for influenza treatment. These medications can be administered via various routes, including orally and others, and are available through different distribution channels, such as retail pharmacies, hospital pharmacies, and others.

The influenza treatment market research report is one of a series of new reports from The Business Research Company that provides influenza treatment market statistics, including influenza treatment industry global market size, regional shares, competitors with a influenza treatment market share, detailed influenza treatment market segments, market trends and opportunities, and any further data you may need to thrive in the influenza treatment industry. This influenza treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The influenza treatment market size has grown steadily in recent years. It will grow from $6.6 billion in 2024 to $6.9 billion in 2025 at a compound annual growth rate (CAGR) of 4.5%. The growth in the historic period can be attributed to a growth in number of annual influenza cases, increased government funding for influenza research and preparedness programs, public awareness campaigns promoting vaccination, the establishment of global influenza surveillance systems, and growth in healthcare facilities.

The influenza treatment market size is expected to see steady growth in the next few years. It will grow to $8.16 billion in 2029 at a compound annual growth rate (CAGR) of 4.3%. The growth in the forecast period can be attributed to the introduction of new antiviral drugs and treatment modalities, expanding vaccination programs, continued expansion and improvement of healthcare infrastructure, increasing elderly population, and development of new treatments. Major trends in the forecast period include progress toward developing universal vaccines, innovations in vaccine delivery systems, integration of AI and big data, advances in personalized medicine, and increased collaborations between pharmaceutical companies.

The rising incidence of contagious respiratory illnesses is anticipated to drive the influenza treatment market forward. Contagious respiratory illnesses encompass infectious diseases such as influenza, measles, or respiratory syncytial virus (RSV) infections, which spread through contact with infected individuals or their bodily fluids, contaminated surfaces, or objects. Factors fueling the increase in contagious respiratory illnesses include higher population densities, inadequate healthcare infrastructure, misuse of antibiotics, and facilitated international travel. Influenza treatment involves the use of antiviral drugs and vaccinations to manage various contagious respiratory illnesses such as flu, COVID-19, and other respiratory viruses. For example, in September 2023, according to the Centers for Disease Control and Prevention (CDC), a US-based national public health agency, the hospitalization rate associated with RSV (Respiratory Syncytial Virus) rose from 2 hospitalizations per 100,000 individuals during the week ending August 5, 2023, to 7 hospitalizations per 100,000 individuals by the week ending on August 19, 2023. Hence, the increased prevalence of contagious respiratory illnesses is propelling the growth of the influenza treatment market.

Prominent companies in the influenza treatment market are concentrating on broadening their product range by introducing innovative solutions, such as single-dose oral medication for influenza treatment, with the aim of enhancing patient adherence, improving treatment outcomes, and securing a larger market share. A single-dose oral medication is a drug formulated to address influenza (flu) with just one oral dose, simplifying the treatment regimen. For example, in August 2022, Genentech Inc., a US-based biotechnology company, revealed the U.S. Food and Drug Administration (FDA) approval for Xofluza (Baloxavir Marboxil). Xofluza stands as the premier and sole single-dose oral medication, providing a convenient and effective solution for managing acute uncomplicated influenza in children aged five to less than 12 years who have exhibited symptoms for no more than 48 hours, as well as other respiratory viruses.

In June 2022, Pfizer Inc., a pharmaceutical company headquartered in the United States, purchased ReViral for an undisclosed sum. This acquisition is aimed at broadening Pfizer's product portfolio by incorporating one of the therapeutic candidates, Sisunatovir, which is an orally administered inhibitor designed to specifically impede the fusion of the respiratory syncytial virus (RSV) with the host cell. ReViral is a biotechnology company based in the United Kingdom, known for its development and provision of innovative therapies for viral diseases.

Major companies operating in the influenza treatment market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bristol-Myers Squibb Company, AstraZeneca plc, Novartis AG, GlaxoSmithKline Plc, Takeda Pharmaceutical Company, Boehringer Ingelheim International GmbH, Gilead Sciences Inc., Fujifilm Holdings Corporation, Viatris Inc., Teva Pharmaceutical Industries Ltd., Janssen Pharmaceuticals Inc., Regeneron Pharmaceuticals Inc., Daiichi Sankyo Company Limited., Chugai Pharmaceutical Co. Ltd., Sun Pharmaceutical Industries Limited, Cipla Ltd, Dr. Reddy's Laboratories Ltd., Lupin Limited, NATCO Pharma Limited, BioCryst Pharmaceuticals Inc., NanoViricides Inc.

North America was the largest region in the influenza treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the influenza treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the influenza treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The influenza treatment market consists of sales of ibuprofen, dextromethorphan, acetaminophen, and nasal sprays. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Influenza Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on influenza treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for influenza treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The influenza treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Product Type: Peramivir; Zanamivir; Oseltamivir Phosphate; Baloxavir Marboxil; Other Products
2) By Route Of Administration: Oral; Other Routes Of Administration
3) By Distribution Channel: Retail Pharmacy; Hospital Pharmacy; Other Distribution Channels
Subsegments:
1) By Peramivir: Intravenous Peramivir; Peramivir Injection
2) By Zanamivir: Inhaled Zanamivir; Zanamivir Diskhaler
3) By Oseltamivir Phosphate: Oseltamivir Capsules; Oseltamivir Oral Suspension
4) By Baloxavir Marboxil: Baloxavir Tablets; Baloxavir Granules For Oral Suspension
5) Other Products: Rimantadine; Amantadine
Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; AbbVie Inc.; Bristol-Myers Squibb Company
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r30475

1. Executive Summary

2. Influenza Treatment Market Characteristics

3. Influenza Treatment Market Trends And Strategies

4. Influenza Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Influenza Treatment Growth Analysis And Strategic Analysis Framework

5.1. Global Influenza Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Influenza Treatment Market Growth Rate Analysis
5.4. Global Influenza Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Influenza Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Influenza Treatment Total Addressable Market (TAM)

6. Influenza Treatment Market Segmentation

6.1. Global Influenza Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Peramivir
Zanamivir
Oseltamivir Phosphate
Baloxavir Marboxil
Other Products
6.2. Global Influenza Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Other Routes Of Administration
6.3. Global Influenza Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Retail Pharmacy
Hospital Pharmacy
Other Distribution Channels
6.4. Global Influenza Treatment Market, Sub-Segmentation Of Peramivir, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Intravenous Peramivir
Peramivir Injection
6.5. Global Influenza Treatment Market, Sub-Segmentation Of Zanamivir, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Inhaled Zanamivir
Zanamivir Diskhaler
6.6. Global Influenza Treatment Market, Sub-Segmentation Of Oseltamivir Phosphate, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oseltamivir Capsules
Oseltamivir Oral Suspension
6.7. Global Influenza Treatment Market, Sub-Segmentation Of Baloxavir Marboxil, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Baloxavir Tablets
Baloxavir Granules For Oral Suspension
6.8. Global Influenza Treatment Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Rimantadine
Amantadine

7. Influenza Treatment Market Regional And Country Analysis

7.1. Global Influenza Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Influenza Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Influenza Treatment Market

8.1. Asia-Pacific Influenza Treatment Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Influenza Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Influenza Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Influenza Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Influenza Treatment Market

9.1. China Influenza Treatment Market Overview
9.2. China Influenza Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Influenza Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Influenza Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Influenza Treatment Market

10.1. India Influenza Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Influenza Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Influenza Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Influenza Treatment Market

11.1. Japan Influenza Treatment Market Overview
11.2. Japan Influenza Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Influenza Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Influenza Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Influenza Treatment Market

12.1. Australia Influenza Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Influenza Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Influenza Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Influenza Treatment Market

13.1. Indonesia Influenza Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Influenza Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Influenza Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Influenza Treatment Market

14.1. South Korea Influenza Treatment Market Overview
14.2. South Korea Influenza Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Influenza Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Influenza Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Influenza Treatment Market

15.1. Western Europe Influenza Treatment Market Overview
15.2. Western Europe Influenza Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Influenza Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Influenza Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Influenza Treatment Market

16.1. UK Influenza Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Influenza Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Influenza Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Influenza Treatment Market

17.1. Germany Influenza Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Influenza Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Influenza Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Influenza Treatment Market

18.1. France Influenza Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Influenza Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Influenza Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Influenza Treatment Market

19.1. Italy Influenza Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Influenza Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Influenza Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Influenza Treatment Market

20.1. Spain Influenza Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Influenza Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Influenza Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Influenza Treatment Market

21.1. Eastern Europe Influenza Treatment Market Overview
21.2. Eastern Europe Influenza Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Influenza Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Influenza Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Influenza Treatment Market

22.1. Russia Influenza Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Influenza Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Influenza Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Influenza Treatment Market

23.1. North America Influenza Treatment Market Overview
23.2. North America Influenza Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Influenza Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Influenza Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Influenza Treatment Market

24.1. USA Influenza Treatment Market Overview
24.2. USA Influenza Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Influenza Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Influenza Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Influenza Treatment Market

25.1. Canada Influenza Treatment Market Overview
25.2. Canada Influenza Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Influenza Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Influenza Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Influenza Treatment Market

26.1. South America Influenza Treatment Market Overview
26.2. South America Influenza Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Influenza Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Influenza Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Influenza Treatment Market

27.1. Brazil Influenza Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Influenza Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Influenza Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Influenza Treatment Market

28.1. Middle East Influenza Treatment Market Overview
28.2. Middle East Influenza Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Influenza Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Influenza Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Influenza Treatment Market

29.1. Africa Influenza Treatment Market Overview
29.2. Africa Influenza Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Influenza Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Influenza Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Influenza Treatment Market Competitive Landscape And Company Profiles

30.1. Influenza Treatment Market Competitive Landscape
30.2. Influenza Treatment Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

31. Influenza Treatment Market Other Major And Innovative Companies

31.1. AstraZeneca plc
31.2. Novartis AG
31.3. GlaxoSmithKline Plc
31.4. Takeda Pharmaceutical Company
31.5. Boehringer Ingelheim International GmbH
31.6. Gilead Sciences Inc.
31.7. Fujifilm Holdings Corporation
31.8. Viatris Inc.
31.9. Teva Pharmaceutical Industries Ltd.
31.10. Janssen Pharmaceuticals Inc.
31.11. Regeneron Pharmaceuticals Inc.
31.12. Daiichi Sankyo Company Limited.
31.13. Chugai Pharmaceutical Co. Ltd.
31.14. Sun Pharmaceutical Industries Limited
31.15. Cipla Ltd

32. Global Influenza Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Influenza Treatment Market

34. Recent Developments In The Influenza Treatment Market

35. Influenza Treatment Market High Potential Countries, Segments and Strategies

35.1 Influenza Treatment Market In 2029 - Countries Offering Most New Opportunities
35.2 Influenza Treatment Market In 2029 - Segments Offering Most New Opportunities
35.3 Influenza Treatment Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer